Novo Nordisk’s Wegovy wins UK approval for use to reduce heart risks

Novo Nordisk’s Wegovy wins UK approval for use to reduce heart risks

Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity.  Nurphoto | Getty Images LONDON — The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk‘s Wegovy weight loss drug to reduce the risk of overweight and obese adults suffering from serious heart problems or strokes. The new approval from … Read more

Lawmakers unveil PBM reform bill amid rising drug costs

Lawmakers unveil PBM reform bill amid rising drug costs

Feverpitched | Getty Images Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication prices and harming U.S. patients and pharmacies. The legislation aims to ensure community pharmacies can provide care to patients enrolled in … Read more

How well can AI chatbots mimic doctors in a treatment setting?

How well can AI chatbots mimic doctors in a treatment setting?

Dr. Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. He is a CNBC contributor and is a member of the boards of Pfizer and several other startups in health and tech. He is also a partner at the venture capital firm New Enterprise Associates. Shani … Read more

A smartphone free childhood? A global movement is growing

A smartphone free childhood? A global movement is growing

Photo: Jaromir Chalabala / Getty LONDON — The evidence linking smartphone use with mental health harms in children is growing and one grassroots organization in the U.K. is supporting parents who are refraining from giving their kids the devices. Smartphone Free Childhood, founded by Daisy Greenwell and Clare Fernyhough in February, set up various group … Read more

Neuralink rival Synchron is using OpenAI models to power chat feature

Neuralink rival Synchron is using OpenAI models to power chat feature

Mark using Synchron’s BCI  Courtesy: Synchron A 64-year-old named Mark has spent the last year learning how to control devices like his laptop and phone using a brain implant. And thanks to OpenAI, it’s gotten a whole lot easier to do.  The neurotech startup Synchron said Thursday it’s using OpenAI’s latest artificial intelligence models to … Read more

Ozempic may lower dementia risk, nicotine use

Ozempic may lower dementia risk, nicotine use

A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond … Read more

These are the 10 worst U.S. states for quality of life

These are the 10 worst U.S. states for quality of life

The job market may have cooled a bit, but there are still far more job openings nationwide than there are people available to fill them. That means qualified workers are still a precious commodity. So, companies seeking to attract great employees like to set up shop in states that offer a great quality of life. … Read more

a $43 million Veterans Affairs simulation hospital

a  million Veterans Affairs simulation hospital

An operating room at SimVET Courtesy: SimVET Inside a sprawling $43 million Veterans Affairs facility equipped with operating rooms, intensive care units and an outpatient clinic, there are no patients. At least not any real ones.  The 53,000-square-foot building sits minutes away from the Orlando International Airport in Florida, and it’s called the National Center … Read more

Drugmakers are racing to develop weight loss pills

Drugmakers are racing to develop weight loss pills

Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills.  Most of the … Read more

Pfizer weight loss pill moves forward as once-daily version

Pfizer weight loss pill moves forward as once-daily version

Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial. The company evaluated several once-daily formulations of the drug and identified one with “the most favorable profile.” Pfizer said it … Read more